REGENERX BIOPHARMACEUTICALS, INC. Notes Payable, Current
REGENERX BIOPHARMACEUTICALS, INC. had Notes Payable, Current of $0 as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2022-05-16
- 2022-03-31: Notes Payable, Current $0.00.
- 2021-12-31: Notes Payable, Current $0.00.
- 2021-09-30: Notes Payable, Current $0.00.
- 2021-06-30: Notes Payable, Current $33.86K.
| Period end | Notes Payable, Current |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $33.86K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $33.86K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $33.86K 10-K · filed 2022-03-30 |
| 2020-09-30 | $33.86K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $24.62K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-02 |